Author: Jeffrey P. Staab, MD, MS
Editorial changes - 2010-01-20
Author information and module status
Posttraumatic Stress Disorder
Select a section to view guidance statement information on Posttraumatic Stress Disorder.
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools
What's New
ACP Members can access the full PIER website.

Alert2009-12-03
FDA MedWatch Safety Alert for Valproate Sodium and related products (valproic acid and divalproex sodium): Risk of Birth Defects
Newly Cited Reference2008-01-01
Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence.
New Reference of Interest2010-01-14
Morphine use after combat injury in Iraq and post-traumatic stress disorder.
more>>
FAQs
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline, Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.